CARsgen Therapeutics Presented at the 2017 BIO International Convention
Jun 23, 2017
SAN DIEGO, June 23, 2017 /PRNewswire/ -- CARsgen Therapeutics (CARsgen), a global biotech start-up focused on developing chimeric antigen receptor T-cell (CAR-T cell) therapies for solid tumors, presented at the 2017 BIO International Convention this week in San Diego, CA.